Stimulation of suicidal erythrocyte death by fumagillin

Basic and Clinical Pharmacology and Toxicology

Volumn 112, Issue 5, 2013, Pages 346-351

  Zbidah, Mohanad ^a   Lupescu, Adrian ^a   Jilani, Kashif ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CERAMIDE; FUMAGILLIN; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DEATH; CELL STIMULATION; CONCENTRATION RESPONSE; CYTOSOL; ERYPTOSIS; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; FLUORESCENCE ANALYSIS; HEMOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SECRETION;

ANNEXIN A5; ANTI-BACTERIAL AGENTS; CALCIUM; CELL DEATH; CELL SIZE; CERAMIDES; CYCLOHEXANES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FATTY ACIDS, UNSATURATED; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; PHOSPHATIDYLSERINES; PROTEIN BINDING; SESQUITERPENES;

ASPERGILLUS FUMIGATUS; FUNGI;

EID: 84876422864     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12033     Document Type: Article

References (79)

1. Yamaguchi J, Hayashi Y. Syntheses of fumagillin and ovalicin. Chemistry 2010;16:3884-901.
2. Lefkove B, Govindarajan B, Arbiser JL. Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors. Expert Rev Anti Infect Ther 2007;5:573-9.
3. Furness MS, Robinson TP, Ehlers T, Hubbard RB, Arbiser JL, Goldsmith DJ et al. Antiangiogenic agents: studies on fumagillin and curcumin analogs. Curr Pharm Des 2005;11:357-73.
4. Venkatraman P. Specificity in the interaction of natural products with their target proteins - a biochemical and structural insight. Mini Rev Med Chem 2010;10:540-9.
5. Wassberg E. Angiostatic treatment of neuroblastoma. Ups J Med Sci 1999;104:1-24.
6. Backman U, Svensson A, Christofferson RH, Azarbayjani F. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis. Anticancer Res 2008;28:1551-7.
7. Zhao Y, Zhou Y, O'Boyle KM, Murphy PV. Hybrids of 1-deoxynojirimycin and aryl-1, 2, 3-triazoles and biological studies related to angiogenesis. Bioorg Med Chem 2008;16:6333-7.
8. Nahari D, Satchi-Fainaro R, Chen M, Mitchell I, Task LB, Liu Z et al. Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer. Mol Cancer Ther 2007;6:1329-37.
9. Owa T, Yoshino H, Yoshimatsu K, Nagasu T. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem 2001;8:1487-503.
10. Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am J Pathol 2001;159:721-31.
11. Kin M, Torimura T, Ueno T, Nakamura T, Ogata R, Sakamoto M et al. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats. Int J Oncol 2000;16:375-82.
12. Yoshida T, Kaneko Y, Tsukamoto A, Han K, Ichinose M, Kimura S. Suppression of hepatoma growth and angiogenesis by a fumagillin derivative TNP470: possible involvement of nitric oxide synthase. Cancer Res 1998;58:3751-6.
13. Mauriz JL, Martin-Renedo J, Garcia-Palomo A, Tunon MJ, Gonzalez-Gallego J. Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours. Curr Drug Targets 2010;11:1439-57.
14. Huang J, Frischer JS, New T, Kim ES, Serur A, Lee A et al. TNP-470 promotes initial vascular sprouting in xenograft tumors. Mol Cancer Ther 2004;3:335-43.
15. Lang F, Gulbins E, Lerche H, Huber SM, Kempe DS, Foller M. Eryptosis, a window to systemic disease. Cell Physiol Biochem 2008;22:373-80.
16. Foller M, Kasinathan RS, Koka S, Lang C, Shumilina E, Birnbaumer L et al. TRPC6 contributes to the Ca(2+) leak of human erythrocytes. Cell Physiol Biochem 2008;21:183-92.
17. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K et al. Regulation of erythrocyte survival by AMP-activated protein kinase. FASEB J 2009;23:1072-80.
18. Brugnara C, de Franceschi L, Alper SL. Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest 1993;92:520-6.
19. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-60.
20. Berg CP, Engels IH, Rothbart A, Lauber K, Renz A, Schlosser SF et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-206.
21. Lang F, Gulbins E, Lang PA, Zappulla D, Foller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 2010;26:21-8.
22. Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M et al. Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
23. Bhavsar SK, Bobbala D, Xuan NT, Foller M, Lang F. Stimulation of suicidal erythrocyte death by alpha-lipoic acid. Cell Physiol Biochem 2010;26:859-68.
24. Foller M, Huber SM, Lang F. Erythrocyte programmed cell death. IUBMB Life 2008;60:661-8.
25. Foller M, Mahmud H, Gu S, Wang K, Floride E, Kucherenko Y et al. Participation of leukotriene C(4) in the regulation of suicidal erythrocyte death. J Physiol Pharmacol 2009;60:135-43.
26. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP et al. In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-56.
27. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2011; in press.
28. Foller M, Feil S, Ghoreschi K, Koka S, Gerling A, Thunemann M et al. Anemia and splenomegaly in cGKI-deficient mice. Proc Natl Acad Sci U S A 2008;105:6771-6.
29. Bhavsar SK, Gu S, Bobbala D, Lang F. Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death. Cell Physiol Biochem 2011;27:547-56.
30. Lauren DJ, Wishkovsky A, Groff JM, Hedrick RP, Hinton DE. Toxicity and pharmacokinetics of the antibiotic fumagillin in yearling rainbow trout (Salmo gairdneri). Toxicol Appl Pharmacol 1989;98:444-53.
31. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM et al. Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-56.
32. Bookchin RM, Ortiz OE, Lew VL. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987;240:193-200.
33. Bratosin D, Estaquier J, Petit F, Arnoult D, Quatannens B, Tissier JP et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ 2001;8:1143-56.
34. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F et al. Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-56.
35. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S et al. Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-43.
36. Kornhuber J, Tripal P, Reichel M, Muhle C, Rhein C, Muehlbacher M et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 2010;26:9-20.
37. Dhami R, He X, Schuchman EH. Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. Cell Physiol Biochem 2010;26:749-60.
38. Becker KA, Grassme H, Zhang Y, Gulbins E. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell Physiol Biochem 2010;26:57-66.
39. Kuebler WM, Yang Y, Samapati R, Uhlig S. Vascular barrier regulation by PAF, ceramide, caveolae, and NO - an intricate signaling network with discrepant effects in the pulmonary and systemic vasculature. Cell Physiol Biochem 2010;26:29-40.
40. Li X, Becker KA, Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem 2010;26:41-8.
41. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007;13:164-70.
42. Walter S, Fassbender K. Spingolipids in multiple sclerosis. Cell Physiol Biochem 2010;26:49-56.
43. Arboleda G, Huang TJ, Waters C, Verkhratsky A, Fernyhough P, Gibson RM. Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells. Eur J Neurosci 2007;25:3030-8.
44. de la Monte SM. Insulin resistance and Alzheimer's disease. BMB Rep 2009;42:475-81.
45. Tong M, Neusner A, Longato L, Lawton M, Wands JR, de la Monte SM. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease. J Alzheimers Dis 2009;17:827-44.
46. Zhao H, Przybylska M, Wu IH, Zhang J, Siegel C, Komarnitsky S et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007;56:1210-8.
47. Zigmond E, Zangen SW, Pappo O, Sklair-Levy M, Lalazar G, Zolotaryova L et al. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat. Am J Physiol Endocrinol Metab 2009;296:E72-8.
48. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008;29:381-402.
49. Felder KM, Hoelzle K, Ritzmann M, Kilchling T, Schiele D, Heinritzi K et al. Hemotrophic mycoplasmas induce programmed cell death in red blood cells. Cell Physiol Biochem 2011;27:557-64.
50. Gatidis S, Zelenak C, Fajol A, Lang E, Jilani K, Michael D et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
51. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupec R et al. The NFkB pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 2011;27:45-54.
52. Lang E, Jilani K, Zelenak C, Pasham V, Bobbala D, Qadri SM et al. Stimulation of suicidal erythrocyte death by benzethonium. Cell Physiol Biochem 2011;28:347-54.
53. Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C, Kaestner L et al. Regulation of phosphatidylserine exposure in red blood cells. Cell Physiol Biochem 2011;28:847-56.
54. Qadri SM, Kucherenko Y, Zelenak C, Jilani K, Lang E, Lang F. Dicoumarol activates Ca-permeable cation channels triggering erythrocyte cell membrane scrambling. Cell Physiol Biochem 2011;28:857-64.
55. Qadri SM, Bauer J, Zelenak C, Mahmud H, Kucherenko Y, Lee SH et al. Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death. Cell Physiol Biochem 2011;28:339-46.
56. Bhavsar SK, Eberhard M, Bobbala D, Lang F. Monensin induced suicidal erythrocyte death. Cell Physiol Biochem 2010;25:745-52.
57. Braun M, Foller M, Gulbins E, Lang F. Eryptosis triggered by bismuth. Biometals 2009;22:453-60.
58. Eberhard M, Ferlinz K, Alizzi K, Cacciato PM, Faggio C, Foller M et al. FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem 2010;26:761-6.
59. Calderon-Salinas JV, Munoz-Reyes EG, Guerrero-Romero JF, Rodriguez-Moran M, Bracho-Riquelme RL, Carrera-Gracia MA et al. Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Mol Cell Biochem 2011;357:171-9.
60. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G Jr et al. Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006;18:223-32.
61. Myssina S, Huber SM, Birka C, Lang PA, Lang KS, Friedrich B et al. Inhibition of erythrocyte cation channels by erythropoietin. J Am Soc Nephrol 2003;14:2750-7.
62. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T et al. Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-88.
63. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J et al. Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:273-81.
64. Siraskar B, Ballal A, Bobbala D, Foller M, Lang F. Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice. Cell Physiol Biochem 2010;26:347-54.
65. Bobbala D, Alesutan I, Foller M, Huber SM, Lang F. Effect of anandamide in Plasmodium Berghei-infected mice. Cell Physiol Biochem 2010;26:355-62.
66. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F. Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-40.
67. Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F. Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2009;23:191-8.
68. Lang PA, Kasinathan RS, Brand VB, Duranton C, Lang C, Koka S et al. Accelerated clearance of Plasmodium-infected erythrocytes in sickle cell trait and annexin-A7 deficiency. Cell Physiol Biochem 2009;24:415-28.
69. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM et al. Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-70.
70. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C et al. Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-7.
71. Zappulla D. Environmental stress, erythrocyte dysfunctions, inflammation, and the metabolic syndrome: adaptations to CO2 increases? J Cardiometab Syndr 2008;3:30-4.
72. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012;302:C644-51.
73. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
74. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-2.
75. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD et al. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-7.
76. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L et al. Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
77. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-80.
78. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS et al. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-21.
79. Zwaal RF, Comfurius P, Bevers EM. Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-88.